ArticleOncogene2017
Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
L Dai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncogene2017
L Dai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.